Vermillion, Inc.
Vermillion, Inc. is involved in the discovery, development and commercialization of diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company uses the process of utilizing advanced protein separation methods to identify and resolve variants of specific biomarkers (known as translational proteomics) for developing a procedure to measure a property or concentration of an analyte (known as an assay) and commercializing diagnostic tests. Vermillion has focuses in the areas of oncology, hematology, cardiology and women’s health. Vermillion’s focus on translational proteomics enables it to address the market for diagnostic tests that measure multiple protein biomarkers. In January 2010, the Company emerged from protection under Chapter 11 of the United States Bankruptcy Code.
Contact Details
Office Address
Vermillion, Inc.
47350 Fremont Blvd.
Fremont, CA, USA 94538
Phone: (510) 226-2800
Fax: (510) 226-2801
Executives
Chairman
Gail S. Page
Consultant Sales and Marketing
William Creech